We got so far behind on that first day on set, so we decided to keep the company on at nights, so the art department could create during the day, Edward says
AOD-9604 typically arrives as lyophilized (freeze-dried) powder in sealed vials requiring reconstitution with bacteriostatic water before injection
Theoretical concerns exist regarding BPC-157s angiogenic properties in the context of cancer
Ignoring Sterility: Reusing a syringe, not wiping the stoppers, working in a dusty area these are all invitations for bacteria
Again, the question isn't "which is better?" It's "what am I trying to investigate?" If the target is a torn muscle in a study animal, a systemic (injectable) application makes sense
Additionally, their flexible dosing allows for treatment adjustments, ensuring therapies are tailored to specific patient responses